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Catalytic Decomposition of Peroxynitrite and Superoxide by Nafion Films 
Modified with  Iron and Manganese Porphyrin 
Amanda Stull, Victor Sarpong, and Dr. John Goodwin 
 
Abstract 
 Nafion films alone and modified with inert electrolytes and metalloporphyrins were 
tested in their effectiveness of decomposition of aqueous peroxynitrite (PN) and superoxide.  
Films that were modified with a cationic manganese porphyrin, which has been shown to be 
responsible for catalytic decomposition of superoxide ion, were found to be most effective.  
Peroxynitrite was generated in solution by the decomposition of 3-morpholinosydnonimime 
(SIN-1) that generates nitric oxide and superoxide ion, which rapidly combine to form 
peroxynitrite.  The tyrosine analogue 4-hydroxyphenylacetic (4-HPA) was used to trap the PN in 
pH 7.00 PBS buffer and was its nitrated product was detected by observing the change in visible 
absorbance at pH 10.  The Nafion films modified with manganese porphyrin were active in 
superoxide quenching and the therefore blocking of peroxynitrite formation throughout a five 
week testing period.  These experiments offer new strategies for disrupting superoxide and 
peroxynitrite in vivo. 
 
Introduction 
 The human body is a complex biological system that recognizes foreign objects and 
diseases.  It will engulf and destroy these intruders to the extent possible.  This creates a problem 
for doctors who want to surgically insert an implant into the human body.  Not only does the 
implant have to survive the human body’s initial defense, an important part of its success is that 
the exterior of the implant be durable and biocompatible.  The implant needs to resist or reduce 
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the inflammatory responses of the body and its tissues.  Scientists have tried several materials 
that mimic the natural cell membrane (discussed later), but these do not last.  In some cases the 
coating must also have specific transport or sensing properties for the implant, creating 
additional requirements for the surface material.  If a better membrane could be found, the 
implants could be more successful.  Scientists are also working on improving drugs and other 
treatments that deal with inflammatory diseases such as arthritis and Crohn’s disease.   
 Immune response involves nitric oxide (NO) which is produced by phagocytes such as 
macrophages, neutriphils, and monocytes. Nitric oxide, a reactive free radical with one unpaired 
electron, is a signal molecule formed in the body that has many functions.  It is known to react 
with the superoxide anion O2
-
, which is also a reactive free radical and oxidizing agent that is 
over-produced during oxidative stress.  The two rapidly combine forming peroxynitrite (ONOO
-
), which is very reactive anion that can decompose to form other free radicals (Holm).  It has 
been shown that peroxynitrites are capable of directly oxidizing and nitrating lipids, proteins, and 
nucleic acids.  Peroxynitrite is important in the inflammation process and is naturally formed 
from nitric oxide and superoxide which are both in high concentrations under conditions of 
oxidative stress.  It also may be responsible for cell death in many inflammatory diseases such as 
arthritis and sepsis (Wang). It has been shown to induce colon and ileum inflammation, and 
edema (Susuki), and much of the damage associated with Alzheimer’s disease (Kopal).   
 There are several different origins of nitric oxides, some forms are made in the body 
naturally and some are induced.  The form that is induced is iNOS, and it is the form that is 
currently under study.  Nitric oxides are produced by inflammatory cytokines and are involved in 
osteoporosis, arthritis, and aseptic loosening of implants (Stea).  Despite further studies and 
innovations, aseptic loosening and osteolysis (bone growing away from the implant causing 
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loosening) occurs frequently in hip implants, and studies have shown that nitric oxides are linked 
to this problem (Puskas).  The body’s self-defense includes:  A.) macrophages that try to destroy 
foreign material but fail to digest the implants and consequently cause chronic inflammation, B.) 
cytokines that deposit collagen around the implant to separate it from the tissue, and C.) 
restriction of blood flow to the implant (Hetrick).  
 Epoxy-polyurethane has been shown to improve the durability and structural strength of 
the implant membrane in mice (Bazung).  It has also been shown that titanium oxide can inhibit 
the reactivity of peroxynitrite in vitro and in mice (Suzuki).  Coating implants with certain 
materials has been and still is being tested to see if they can survive longer inside the body.  
Nafion, a teflon-crosslined perfluoronated sulfonate polymer, widely used in fuel cells, has also 
been studied extensively as a membrane coating for implantable glucose sensors that would be 
beneficial in the treatment of diabetes, since it is a solid electrolyte, capable of transporting 
cations and small neutral molecules as needed for the sensor.  It has relatively good 
biocompatibility and function for these sensors and has been shown to withstand the tough 
environment of the body for limited periods of time. Nafion has shown to withstand many acids 
and oxides that usually cause inflammation and degradation of the membrane, but it loses its 
characteristics as calcium ions collect in the anionically charged pores of its structure leading to 
cracking of the polymer (Mercado). 
 Many scientists have proved that metalloporphyrins are successful decomposition 
catalysts of PN.  In vitro and in the body, two substances that are known to be PN decomposition 
catalysts are the water-soluble porphyrins FeTMPyP and FeTPPS.  They have shown to be 
neuroprotective in rats with cerebral ischemia (Dhar).  Other agents can be used to react with PN 
and other oxidizing agents stoichiometrically rather than catalytically, requiring replacement 
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with periodic dosages.  Thiols, for example, have been used since they are thought to remove 
very reactive hydroxyl radicals from the environment, so that nitric oxides do not become the 
highly reactive and damaging peroxynitrites.  When added with the nitric oxides, the damaging 
effects were eradicated (Kopal). Two other substances used to block the harmful effects of 
peroxynitrites are penicillamine, a scavenger of peroxynitrite, and tempol, a catalytic scavenger 
of peroxynitrite (Singh). 
 When doing experiments in vitro, nitric oxide and peroxynitrites from the body are 
usually not used since they decompose rapidly.  To mimic their formation in the body, 
peroxynitrite must be generated at low concentration at a relatively constant rate.  To accomplish 
this, a reagent known as SIN-1 (3-Morpholinosydnonimine) is used because it slowly 
decomposes in air to make peroxynitrite by forming both NO and the superoxide anion, which 
react to form peroxynitrite.  Peroxynitrite’s effects are also modeled chemically by using a 
reagent similar to the tyrosine peptide, since PN is known to nitrate this peptide very quickly in 
its damage to proteins.  This capturing reagent, 4-hydroxyphenylacetic acid (4-HPA), shows a 
measurable color change upon nitration.  The SIN-1 and 4-HPA, therefore make a convenient 
chemical model system for measuring the persistence of peroxynitrite in the presence of a 
potential implant surface.  Indeed, the presence of peroxynitrite in the body is usually assessed 
by the nitration of tyrosine in proteins (Holm).  If there is damage done by PN, nitrated tyrosine 
will be present and if there is no damage, only normal tyrosine will be present. 
In previous experiments, Nafion was examined in its ability to disrupt the formation and to 
decompose peroxynitrite with this in vitro model based on SIN-1 and 4-HPA.  The Nafion was 
used alone and modified with inert electrolytes and the catalytic metalloporphyrins FeTMpyP 
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and MnTMpyP.  My experiments involved examination of the longevity of the effectiveness of 
MnTMpyP in this system. 
Materials and Methods 
 Nafion was soaked in aqueous manganese porphyrin and air dried.  Solutions of PBS (pH 
7.00), 0.001 mol 4-HPA (Sigma Aldrich 98%), and Sigma Aldrich 0.010 mol of SIN-1 
anhydrous stock were made at different volumes; 2mL, 3mL, and 6mL.  At each volume, dry 
SIN-1 and 4-HPA were combined and PBS was added until the desired volume was reached.  
The 6 mL solution contained 0.913 mg 4-HPA and 12.4 mg SIN-1.  The 3 mL solution had 0.456 
mg of 4-HPA and 6.20 mg of SIN-1.  The 2 mL solution had 0.304 mg of 4-HPA and 4.13 mg 
SIN-1.  A pipette was used to place 1.0 mL of each sample into separate vials.  For the second 
and third solutions, a control was set up without Nafion film.  Three controls were set up for the 
first solution.  A hole punch sized (0.5027 mm
2
) presoaked Nafion film was then placed in the 
each of the rest of the vials.  The vials were sealed, labeled, and placed in a 37
0
C incubator.  In 
two days, a control vial and a vial with presoaked Nafion film from the 6 mL volume were 
analyzed using a UV/VIS Ocean Optics Spectrophotometer.  Each sample was buffered to pH 
10.00, with a total of 2 mL of solution being added to the UV/VIS cuvette.  Spectral analysis was 
detected and examined.  At one, two, and three weeks the same procedures were used to evaluate 
a control vial and a vial with Nafion from the 6 mL volume again.  At the end of five weeks, the 
6 mL, 3 mL, and 2 mL volumes were analyzed.  Spectra were taken for a control vial and a vial 






 At the end of five weeks, there was a visual difference between control vials and vials 
with presoaked Nafion. The control vials had a deep yellow color in appearance, while the vials 
with presoaked Nafion had more of a clear appearance, showing no change in color.  The change 
in color represents the nitration of 4-HPA.  The nitration is further analyzed with the use of 
UV/VIS.  A UV/VIS Ocean Optics Spectrophotometer was used to find the absorbance and 
wavelength values of each vial.  Peroxynitrite shows up on the spectra between around 410 to 





































Figure 1:  Bar graph showing the absorbance values at a wavelength of 410.18nm.  The bar 
graph shows the blockage of PN by presoaked Nafion at different concentrations.  The vials with 
presoaked Nafion show a very low absorbance, while control samples show high absorbance due 































Figure 2:  Bar graph showing the absorbance values at a wavelength of 422.16nm.  The bar 
graph shows the blockage of PN by presoaked Nafion at different concentrations.  The vials with 
presoaked Nafion show a very low absorbance, while control samples show high absorbance due 




 The change in color of only the control vials shows that the presoaked Nafion was 
successful in blocking PN formation.  The UV/VIS spectra also support this. The bar graphs 
show the blockage of PN by presoaked Nafion at different concentrations.  The vials with 
presoaked Nafion show a very low absorbance at the wavelengths where PN is found, while 
control samples show high absorbance due to nitration of 4-HPA.  The blockage of PN by 
presoaked Nafion was shown at all time intervals, up until the last analysis at 5 weeks.  Since 
part of the current problem with films is its durability, it is significant that it was successful for 
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